- New CGMS iPro Continuous Glucose Recorder is small, lightweight, and easy to use
- CGMS iPro Recorder can substantially improve therapy optimization
- CGM technology reveals key clinical insights not apparent with fingerstick and A1C testing alone 1-5
- Medtronic Diabetes CGM technology is validated in more than 200 clinical publications
- Product and healthcare provider reimbursement is in place
- Industry-leading service and support eases the way for you and your patients
- 1
- Skyler JS. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system. Diabetes Technol Ther. 2000;2(suppl 1):S7-S12.
- 2
- Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther. 2000;2(suppl 1):S19-S26.
- 3
- Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24(12):2030-2034.
- 4
- Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract. 1999;46(3):183-190.
- 5
- Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2732.